RochePrefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Roche (RHHBY) reported revenue of $34.26B in Q4 2025.
RocheSwiss diversified pharma. Carmot acquisition (December 2023, $2.7B) brought CT-388 (about 23% placebo-adjusted weight loss at 48 weeks Phase 2), CT-996 oral, and CT-868. Zealand licensing deal ($1.65B) added petrelinitide amylin program.
Roche (RHHBY) is a Drug Manufacturers - General company. Swiss diversified pharma. Carmot acquisition (December 2023, $2.7B) brought CT-388 (about 23% placebo-adjusted weight loss at 48 weeks Phase 2), CT-996 oral, and CT-868. Zealand licensing deal ($1.65B) added petrelinitide amylin program. It was founded in 1896, is headquartered in Basel, Switzerland and employs about 103,249 people.
Track Roche's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated September 28, 2026.
Sterling groups Roche in the GLP-1 industry, alongside Pfizer (PFE), Amgen (AMGN), AstraZeneca (AZN), Merck & Co. (MRK) and AbbVie (ABBV).
If you are researching Roche, also look at Pfizer (PFE), Amgen (AMGN) and AstraZeneca (AZN). You can compare all of them side by side or browse the full GLP-1 industry on Sterling.
H1 2016-H2 2025
H1 2016-H2 2025